Moreover, biomarkers of myocardial injury and inflammation such as cardiac troponin I (cTnI) (27) and high-sensitivity C-reactive protein (hsCRP) (28) presented no significant difference between CAD-NAFLD group and CAD group. This evidence concerns the gene TNNI3 and metabolic dysfunction-associated steatotic liver disease.